Prescription Drug Prices – Policy & Medicine

PhRMA Reiterates Dangers of Price Setting Provisions in the IRA

The Unintended Consequences of State Prescription Drug Affordability Boards

HHS OIG Issues Advisory Opinion 24-02, Focused on Patient Assistance Funds

Sandoz Reaches $265 Million Price-Fixing Settlement

CMS Must Withdraw Copay Assistance Rule

States Are Starting to Adopt Drug Price Boards

Kaiser Family Foundation Report Finds Drug Prices Increased Faster than Inflation

Connecticut Governor Proposes Price Restrictions on Prescription Drugs

Generic Drugs Reduce Per Capita Spending on Prescription Drugs

Three Generic Pharmaceutical Manufacturers Agree to $447 Million Settlement for False Claims Act Violations